Literature DB >> 22534569

MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.

Alicja Solatycka1, Tomasz Owczarek, Friedrich Piller, Véronique Piller, Bartosz Pula, Lukasz Wojciech, Marzena Podhorska-Okolow, Piotr Dziegiel, Maciej Ugorski.   

Abstract

A good correlation between the expression of mucin1 (MUC1) and T antigen was found in breast cancer tumors and breast cancer cell lines, especially after treatment with neuraminidase. The association between the appearance of T antigen and the overexpression of MUC1 was further confirmed by transfecting MDA-MB-231 cells and murine 4T1 mammary carcinoma cells with cDNA for MUC1 and using an RNAi approach to inhibit the expression of MUC1 gene in T47D cells. Furthermore, we discovered that in 4T1 cells which express the sialyl Le(X) antigen, overexpression of MUC1 caused not only appearance of T antigen, but also loss of the sialyl Le(X) structure. As the observed changes in O-glycan synthesis can be associated with changes in the expression of specific glycosyltransferases, core 1 β1,3-galactosyltransferase, core 2 β1,6-N-acetylglucosaminyltransferase (C2GnT1) and β-galactoside α2,3-sialyltransferase (ST3Gal I), we studied their expression in parental, vector-transfected and MUC1-transfected MDA-MB-231 and 4T1 cells as well as T47D cells transduced with small hairpin RNA targeted MUC1 mRNA. It was found that the expression of C2GnT1 and ST3Gal I is highly decreased in MUC1-expressing MDA-MB-231 and 4T1 cells and increased in T47D cells with suppressed expression of MUC1. Therefore, we found that changes in the structure of O-linked oligosaccharides, resulting in the occurrence of T antigen, are at least partially associated with MUC1 overexpression which down-regulates the expression of C2GnT1 and ST3Gal I. We showed also that the overexpression of MUC1 in 4T1 cells changes their adhesive properties, as MUC1-expressing cells do not adhere to E-selectin, but bind galectin-3.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22534569     DOI: 10.1093/glycob/cws075

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  12 in total

1.  MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.

Authors:  Satish Sagar; Pramila D Leiphrakpam; Divya Thomas; Kyle L McAndrews; Thomas C Caffrey; Benjamin J Swanson; Henrik Clausen; Hans H Wandall; Michael A Hollingsworth; Prakash Radhakrishnan
Journal:  Cancer Lett       Date:  2021-01-22       Impact factor: 8.679

Review 2.  Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.

Authors:  Andréia Vasconcelos-Dos-Santos; Isadora A Oliveira; Miguel Clodomiro Lucena; Natalia Rodrigues Mantuano; Stephen A Whelan; Wagner Barbosa Dias; Adriane Regina Todeschini
Journal:  Front Oncol       Date:  2015-06-25       Impact factor: 6.244

3.  Development of Monoclonal Antibodies against CMP-N-Acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3Gal-I) Recombinant Protein Expressed in E. coli.

Authors:  Anuj Kumar Gupta; Parvinder Kaur; Harshada Patil; Pallavi Kadam; Paresh B Bhanushali; Manoj Chugh
Journal:  Biochem Res Int       Date:  2015-12-10

4.  Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.

Authors:  Tomasz B Owczarek; Jarosław Suchanski; Bartosz Pula; Alicja M Kmiecik; Marek Chadalski; Aleksandra Jethon; Piotr Dziegiel; Maciej Ugorski
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 5.  Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).

Authors:  Ryan L Hanson; Michael A Hollingsworth
Journal:  Biomolecules       Date:  2016-07-30

6.  The Novel Type 1 Fimbriae FimH Receptor Calreticulin Plays a Role in Salmonella Host Specificity.

Authors:  Krzysztof Grzymajlo; Maciej Ugorski; Jaroslaw Suchanski; Anna E Kedzierska; Rafal Kolenda; Anna Jarzab; Agnieszka Biernatowska; Peter Schierack
Journal:  Front Cell Infect Microbiol       Date:  2017-07-19       Impact factor: 5.293

7.  A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer.

Authors:  Amedeo Amedei; Fatemeh Asadzadeh; Francesco Papi; Maria Giuliana Vannucchi; Veronica Ferrucci; Iris A Bermejo; Marco Fragai; Carolina Vieira De Almeida; Linda Cerofolini; Stefano Giuntini; Mauro Bombaci; Elisa Pesce; Elena Niccolai; Francesca Natali; Eleonora Guarini; Frank Gabel; Chiara Traini; Stefano Catarinicchia; Federica Ricci; Lorenzo Orzalesi; Francesco Berti; Francisco Corzana; Massimo Zollo; Renata Grifantini; Cristina Nativi
Journal:  iScience       Date:  2020-06-06

Review 8.  Altered tumor-cell glycosylation promotes metastasis.

Authors:  Irina Häuselmann; Lubor Borsig
Journal:  Front Oncol       Date:  2014-02-13       Impact factor: 6.244

9.  Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma.

Authors:  Han Wu; Xue-Liang Shi; Hai-Jian Zhang; Qing-Jie Song; Xiao-Bing Yang; Wei-Dong Hu; Guang-Lin Mei; Xi Chen; Qin-Sheng Mao; Zhong Chen
Journal:  Onco Targets Ther       Date:  2016-04-18       Impact factor: 4.147

10.  Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape.

Authors:  Christian Garbar; Corinne Mascaux; Yacine Merrouche; Armand Bensussan
Journal:  Cancer Manag Res       Date:  2018-05-04       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.